An integrated team of pathologists, biologists, data scientists, and AI experts adapts our models to each program's data and scientific objectives, delivering interpreted tissue intelligence rather than standalone software.
Extract structured, reproducible spatial features across H&E, IHC, mIF, and spatial transcriptomics, connecting tissue biology to clinical outcomes to deliver actionable biomarker insights and enable patient selection.
Every finding is traceable to its source image, enabling scientists and pathologists to review and verify results against the original tissue slide.
Established analytical workflows and mature quality and information-security systems support reproducible analysis at scale, from discovery through late clinical development, with a path to clinical trial assay and CDx deployment.
